Royal Society predicts that personalised medicines are still decades awayBMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7518.656-b (Published 22 September 2005) Cite this as: BMJ 2005;331:656
- Susan Mayor
The clinical use of personalised medicines, where patients are prescribed treatments based on their genetic make-up, will not occur for at least another 15-20 years, according to a report published this week by the Royal Society, the UK's national academy of science.
The report was developed by a Royal Society working group to provide a balanced assessment of the future potential and limitations of pharmacogenetics—how genetic make-up affects response to medicines.
The group heard evidence from a wide range of organisations and individuals, in addition to views from three public workshops. It concluded that pharmacogenetics has a promising future but that it will …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial